The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 2231600 |
7 |
Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole. |
Pfizer |
| 2342053 |
20 |
Conformation-activity relationship study of 5-HT3 receptor antagonists and a definition of a model for this receptor site. |
Merrell Dow Research Institute |
| | 5 |
Design and synthesis of novel ligands for the 5-HT3 and the 5-HT4 receptor |
TBA |
| 16722631 |
87 |
An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression. |
Predix Pharmaceuticals |
| 7837236 |
19 |
(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity. |
Sandoz Pharma |
Search and Browse
